Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/981
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Erythromycin (Capsule, Delayed Release)
|
| dailymed-instance:descripti... |
Erythromycin Delayed-release Capsules contain enteric-coated
pellets of erythromycin base for oral administration. Each Erythromycin Delayed-release
Capsule contains 250 milligrams of erythromycin base.<br/>Inactive Ingredients: Cellulosic polymers, citrate ester, D&C Red
No. 30, D&C Yellow No. 10, magnesium stearate and povidone. The capsule
shell contains FD&C Blue No. 1, FD&C Red No. 3, gelatin, and titanium
dioxide. Erythromycin is produced by a strain
of Saccharopolyspora erythaea (formerly Streptomyces erythraeus) and belongs to the
macrolide group of antibiotics. It is basic and readily forms salts with
acids but it is the base which is microbiologically active. Erythromycin
base is (3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-��-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-��-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione. CHNOMW
734
|
| dailymed-instance:activeIng... | |
| dailymed-instance:genericDr... | |
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... |
dailymed-ingredient:Cellulosic_polymers,
dailymed-ingredient:D&C_Red_No._30,
dailymed-ingredient:D&C_Yellow_No._10,
dailymed-ingredient:FD&C_Blue_No._1,
dailymed-ingredient:FD&C_Red_No._3,
dailymed-ingredient:citrate_ester,
dailymed-ingredient:gelatin,
dailymed-ingredient:magnesium_stearate,
dailymed-ingredient:povidone,
dailymed-ingredient:titanium_dioxide
|
| dailymed-instance:genericMe... |
Erythromycin
|
| dailymed-instance:fullName |
Erythromycin (Capsule, Delayed Release)
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Erythromycin
|